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Macrophage activation is essential for protection
against bacterial pathogens but needs to be
regulated to prevent damage to the host. We show
a key role for the immune inhibitory receptor
CD200R and its ligand CD200 in the context of infec-
tionwith theGram-negative humanpathogenNeisse-
ria meningitidis. N. meningitidis induced CD200 but
downregulatedCD200Ronmacrophages inamanner
dependant onNeisserial lipopolysaccharide, Toll-like
receptor-4 (TLR-4), and theMyD88pathwaybut inde-
pendent of a known Neisserial receptor, scavenger
receptor A (SR-A). Agonists of the pattern-recogni-
tion receptors nucleotide oligomerization domain 2
(NOD2) and NACHT-LRR protein 3 (NALP3) also
inducedCD200.TheNF-kBmemberc-Relwasessen-
tial for TLR-, NOD2-, and NALP3-mediated induction
of CD200. CD200/ animals showed higher lethality
in response to experimental meningococcal septi-
cemia, inducedhigher levels ofproinflammatory cyto-
kines, and recruited increased numbers of activated
leukocytes, despite comparable bacterial clearance.
Thus CD200 is induced by TLR-, NOD2-, and NALP3-
mediated pathways, limiting their function and pro-
tecting the host from excessive inflammation.
INTRODUCTION
Activated macrophages (Mf) initiate phagocytosis and inflam-
mation in response to infection and injury, promoting killing
and repair. However, uncontrolled host responses often lead to
inflammatory pathologies. Pathogen-sensing pattern recogni-
tion receptors (PRRs) such as Toll-like receptors (TLRs) and
NOD-like receptors (NLRs, includingNOD1/2 andNALPs) induce
‘‘innate immune activation’’ of Mf after recognition of microbial
or endogenous ‘‘danger’’ molecules (Creagh and O’Neill,236 Cell Host & Microbe 8, 236–247, September 16, 2010 ª2010 Els2006). Phagocytic PRRs such as scavenger receptors (SRs)
and C-type lectin receptors (CLRs) contribute to innate activa-
tion either by collaboration with TLRs and NLRs or by directly
modulating adhesion and migration of Mf (Mukhopadhyay
et al., 2004; Underhill, 2003). In addition to innate activation,
T helper 1 (Th1) and Th2 lymphocyte-derived cytokines inter-
feron-g (IFN-g) and interleukin-4 (IL-4) can induce distinct ‘‘clas-
sical’’ (Mosser, 2003) and ‘‘alternative’’ (Gordon, 2003; Martinez
et al., 2009) Mf activation, respectively, and further regulate
inflammatory responses of innately activated Mf. Functional
dysregulation of PRRs and of IFN-g and IL-4 pathways has
been implicated in a variety of inflammatory disorders (Farrar
and Schreiber, 1993; Karin et al., 2006; Wynn, 2003). Therefore,
endogenous regulatory pathways must exist to protect the host
by limiting excessive inflammation. Indeed, a number of negative
regulators of inflammation have been identified, but their thera-
peutic potential remains to be determined (Han and Ulevitch,
2005; Nathan, 2002).
Numerous inhibitory receptors have been described on
myeloid cells and are likely to be involved in the control of
immune responses (Ravetch and Lanier, 2000; Yamada and
McVicar, 2008). CD200 and its receptor CD200R is one of the
best-characterized immune inhibitory ligand-receptor pairs
(Barclay et al., 2002; Nathan and Muller, 2001). Manipulation of
this pathway has been shown to have therapeutic promise in
experimental models of chronic inflammation (Gorczynski,
2005). CD200 and CD200R are both cell-surface glycoproteins
that contain two immunoglobulin superfamily domains. CD200
is broadly expressed on many cell types, whereas CD200R
expression is present on most leukocytes but at higher levels
on myeloid cells. Interaction between CD200 and CD200R
through their membrane-distal Ig domains transmits an inhibitory
signal to the myeloid cells through CD200R, which contains
three conserved tyrosine residues. By contrast, CD200 is
thought to be signal incompetent, because of its short intracel-
lular tail without any known signaling motifs. CD200/ animals
show increased susceptibility to a range of autoimmune and
inflammatory diseases (Hoek et al., 2000). This is due to loss of
ligand-induced inhibitory signaling through CD200R. A similar
phenotype has been seen in wild-type (WT) animals afterevier Inc.
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bodies (Wright et al., 2000) and confirmed by the phenotype of
mice lacking CD200R (Boudakov et al., 2007). By contrast, infu-
sion of CD200-Ig fusion proteins and agonistic antibody to
CD200R ameliorated even established pathologies (Copland
et al., 2007; Snelgrove et al., 2008). These findings confirmed
a nonredundant myeloid-specific inhibitory function for CD200-
CD200R interaction. Most of the studies utilized chronic autoim-
mune models of disease, usually driven by antigen-specific
lymphocytes, yet no evidence was found for primary lymphocyte
hypersensitivity, and hyperactivated Mf populations almost
always dominated inflammation (Hoek et al., 2000; Wright
et al., 2000). The essential requirement for adjuvants in the induc-
tion of disease further points to a role for innate immune activa-
tion of Mf (Nathan and Muller, 2001).
We investigated howCD200 andCD200R are regulated during
innate and cytokine-mediatedMf activation and defined the role
of CD200 in modulating various innate receptor pathways to limit
inflammation. We report that the pathogen-sensing PRRs TLRs,
nucleotide oligomerization domain 2 (NOD2), and NACHT-LRR
protein 3 (NALP3), but not phagocytic scavenger receptor
A (SR-A), differentially upregulate CD200 and downregulate
CD200R expression on innately activated Mf through the
NF-kB family transcription factor c-Rel. In turn, CD200-
CD200R interaction specifically inhibits TLR-, NOD2-, and
NALP3-mediated innate inflammatory responses, both ex vivo
and in vivo, and is essential to protect the host from experimen-
tally induced lethal meningococcal septicemia.
RESULTS
Neisseria meningitidis Induces CD200
and Downregulates CD200R Expression
on Various Mf Populations
We compared CD200 and CD200R expression on defined Mf
populations such as biogel-elicited peritoneal Mf (Bg-PM), thio-
glycollate-elicited peritoneal Mf (TPM), and bone marrow
culture-derived Mf (BMDM) after innate (Neisseria meningitidis
[NM] stimulated), classical (IFN-g-treated), and alternative
(IL-4-treated) activation. Analysis showed no CD200 surface
expression in unstimulated BMDM and Bg-PM from Balb/c
mouse strain (Figure 1A, and low level basal expression in
Bg-PM from C57BL/6J strain (Figure 1B). However, irrespective
of genetic background, CD200 expression was significantly
induced in these Mf populations after NM treatment (Figure 1A
and data not shown). In contrast, CD200 was constitutively
expressed at high levels on Mf elicited with thioglycollate broth
(TPM), and NM treatment failed to further increase CD200
expression in this population (Figure 1A and data not shown).
Interestingly, IFN-g or IL-4 treatment did not induce CD200 in
any of these Mf populations (Figure S1, available online), indi-
cating that CD200 is an inducible and selective marker for Mf
innate activation. In contrast to CD200, all three Mf populations
(Bg-PM, BMDM, and TPM) constitutively expressed high levels
of CD200R, which showed a marked downregulation after NM
treatment in Bg-PM and TPM and to a lesser extent in BMDM
(Figure 1A). We have confirmed that downregulation in
CD200R expression was not due to enhanced cell death
following stimulation (data not shown).Cell Host &Neisseria meningitidis Differentially Regulates CD200
andCD200R, Independent of SR-A, butDoesRequire the
LPS-TLR-4-MyD88 Signaling Axis
TLR-4 and SR-A are two major PRRs on Mf that recognize NM
through lipopolysaccharide (LPS)- and -independent mecha-
nisms, respectively (Peiser et al., 2002). To determine the mech-
anism by which NM differentially regulates CD200 and CD200R,
we tested the potential contributions of SR-A, TLR-4 pathways,
andNeisserial LPS. No difference in CD200 induction or CD200R
downmodulation was observed between NM-treated WT and
SR-A/Bg-PM (Figure 1B), indicating that SR-A was not essen-
tial for NM-mediated regulation of these two molecules.
To test potential involvement of Neisserial LPS on CD200 and
CD200R regulation, we stimulated Bg-PM from WT mice with
either an LPS-sufficient NM strain H44/76 or its LPS-deficient
isogenic mutant strain H44/76lpxA and analyzed CD200 and
CD200R expression. The H44/76lpxA strain failed to upregulate
CD200 or downregulate CD200R expression on Mf (Figure 1C),
indicating that Neisserial LPS is essential for differential regula-
tion of these two surface proteins.
The role of TLR-4 in the regulation of CD200 and CD200R was
investigated by comparing CD200 and CD200R expression on
Bg-PM between C3H/HeJ (lacking functional TLR-4) and C3H/
HeN (corresponding WT control) mouse strains after stimulation
with the LPS-sufficient NM strain MC58. NM failed to induce
CD200 and downregulate CD200R on TLR-4-deficient Mf,
confirming the essential requirement of TLR-4 (Figure 1D).
TLR-4 utilizes both MyD88- and TRIF-dependent signaling path-
ways. NM failed to induce CD200 or downmodulated CD200R
expression in MyD88/ Mf (Figure 1E), confirming that the
MyD88-dependent TLR-4 signaling pathway is responsible for
differential regulation of CD200 and CD200R. We further
confirmed that CD200R downregulation is independent of
CD200, since NM-mediated CD200R downregulation occurs
efficiently in CD200/ Mf (data not shown).
The NF-kB Family Member c-Rel Is Essential
for TLR-Mediated Transcription of CD200 mRNA
To determine the mechanism controlling induction of CD200, we
investigated whether LPS-mediated induction of CD200 is tran-
scriptionally regulated and the role of c-Rel, a key member of the
NF-kB transcription factor family, downstream of MyD88. LPS
stimulation induced CD200 mRNA in WT BMDM. However,
CD200 transcription was profoundly deficient in BMDM from
c-Rel/mice (Figure 2). This suggests that c-Rel controls the
transcriptional activation of the CD200 gene downstream of
MyD88. A range of other TLR agonists such as PGN (TLR-2/6),
Poly I:C (TLR-3), and CpG DNA (TLR-9) also induced CD200
mRNA in a c-Rel-dependent manner. Thus, TLR signaling can
induce CD200 transcription, and that depends on c-Rel. In
contrast to their effects on CD200 expression, various TLR
agonists showed only modest downregulation of CD200R
mRNA synthesis in both WT and c-Rel/ Mf (data not shown).
These data suggest that although CD200 upregulation depends
on c-Rel-mediated new mRNA synthesis, downregulation of
CD200R is not due to reduced transcription of the cd200R
gene and is possibly regulated by other cellular mechanisms
such as altered receptor recycling, degradation, or mRNA
stability.Microbe 8, 236–247, September 16, 2010 ª2010 Elsevier Inc. 237
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Figure 1. NM Treatment Differentially Regulates Surface Expression of CD200 and CD200R on Various Elicited Mf Populations
The pink lines on histograms show surface expression after NM treatment. Green lines and filled histograms represent expression in untreated control cells and
after staining with isotype-matched control mAb, respectively. Each treatment condition was analyzed in triplicates and data are representative of three inde-
pendent experiments.
(A) Flow cytometry showing surface expression of CD200 and CD200R on Bg-PM, BMDM, and TPM isolated from Balb/c mice after NM treatment (20 NM/Mf).
(B) Flow cytometry showing that the differential regulation of CD200 and CD200R surface expression is the same on bothWT and SR-A/Bg-PM after NM treat-
ment (20 NM/Mf); therefore, regulation is independent of SR-A.
(C) Flow cytometry showing CD200 andCD200R expression on Bg-PMafter stimulation with aWT (H44/76) or a LPSmutant (H44/76lpxA) NM strain indicates that
Neisserial LPS is essential for differential regulation of CD200 and CD200R.
(D) Flow-cytometry analysis showing CD200 and CD200R expression on Bg-PM from TLR-4mutant C3H/HeJ andWTC3H/HeNmice, after NM treatment. Histo-
gram shows that TLR-4 is essential for differential regulation of CD200 and CD200R expression.
(E) Flow-cytometry analysis of CD200 and CD200R expression on Bg-PM from WT and MyD-88/ mice after NM treatment shows that MyD-88 is essential for
differential regulation of CD200 and CD200R.
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Figure 2. NF-kB Family Member c-Rel Is
Essential for CD200 Induction by Specific
TLR Agonists
Fold changes in CD200 mRNA expression are
shown after stimulating BMDM from WT and
c-Rel/ mice with agonists of selected TLRs,
LPS, CpG, peptidoglycan, and poly I:C for indi-
cated times. Data are shown as mean ± SD, with
3 mice per group. Each treatment condition was
analyzed in triplicate and data are representative
of three independent experiments.
Cell Host & Microbe
CD200 Inhibits TLR and NLR FunctionCD200–/– Mice Are More Susceptible to Experimental
Meningococcal Septicemia
We studied the in vivo role of CD200 in acute inflammation
induced byN. meningitidis, by using a well-characterized murine
model of meningococcal septicemia with the serogroup B strain
ofN.meningitidisMC58. BothWT and CD200/ strains showed
signs of infection but at 40 hr after injection, the health of the
CD200/ animals declined dramatically and almost all the
animals in this group had to be culled (Figure 3A). In contrast,
38.6% of the WT animals recovered and remained healthy until
the experiment was terminated at 120 hr (Figure 3B). No signifi-
cant differences were observed in the levels of bacteremia in
blood and in the spleen of CD200/ animals compared to WT
animals (Figure 3C). However, levels of IL-6, a marker for
systemic inflammation, were significantly higher in CD200/
mice than in WT mice (Figure 3D). Taken together, these data
suggest that the enhanced susceptibility of CD200/ mice is
associated with an exacerbated systemic inflammatory
response rather than higher levels of bacteremia.CD200–/– Mice Show an Enhanced Inflammatory
Response during Sterile Peritonitis Induced by
Inactivated NM
To define the early events of NM-mediated inflammatory
response in vivo, we adopted a sterile peritonitis model utilizing
inactivated NM and analyzed inflammatory cell recruitment and
cytokine responses 2 hr after injection. phosphate-buffered
saline (PBS)-injected CD200/ mice showed significantly
higher numbers of F4/80hiCD11bhiGR-1-ve resident peritoneal
Mf (these cells were also negative for CD11c and CD19) in their
peritoneal cavity compared to WT mice. The number of resident
Mf decreased in both strains after NM injection, possibly
because of their emigration into lymphatics (Figure 4A). ResidentCell Host & Microbe 8, 236–247, SeMf from PBS-injected CD200/ animals
expressed higher levels of major his-
tocompatibility complex class II (MHC-II)
constitutively. After NM injection, MHC-II
was enhanced on this population
in both strains, but induction was
significantly higher in CD200/ ani-
mals (Figure 4A, inset). In contrast to
resident Mf, inflammatory monocyte
(F4/80lowCD11b+veGR-1med) and neutro-
phil (CD11bhiGR-1hiF4/80-ve) populations
were recruited in both mouse strains, but
induced recruitment was significantlyhigher in CD200/ mice compared to the WT strain (Figure 4A).
Higher levels of TNF-a and IL-6 were present in the lavage fluid
from NM-injected CD200/ mice compared to WT mice
(Figure 4B). No TNF-a or IL-6 was detected in the PBS-injected
groups of either strain. To exclude the possibility that phago-
cytes from CD200/ mice were more efficient in engulfing NM
and therefore produced more cytokines, we compared uptake
of NM in vivo between the two strains. Mice were injected intra-
peritoneally with fluorescently labeled inactivated NM, peritoneal
exudate cells were isolated and fixed, and total NM uptake was
measured by flow cytometry. No difference in uptake was
observed between the two strains (Figure 4B). To evaluate the
inflammatory response of CD200/ Mf in isolation, we stimu-
lated Bg-PM from WT and CD200/ mice with different doses
of inactivated NM for 16 hr and measured TNF-a and IL-6 levels
in culture supernatants. CD200/ Mf consistently produced
significantly higher levels of TNF-a and IL-6, compared to WT
Mf (Figure 4C). Similar to the in vivo experiments, WT and
CD200/Bg-PM showed no significant difference in NMuptake
in vitro (Figure 4C). Thus CD200/ Mf show an exaggerated
inflammatory response to NM, independent of uptake.CD200–/– Mf Are Hyperresponsive to Purified TLR
Agonists
To test whether the hyperinflammatory response of CD200/
Mf extended to defined TLR agonists, we stimulated Bg-PM
from WT and CD200/ mice with different concentrations of
selected TLR agonists, such as LPS (TLR-4), PGN (TLR-2/6),
and poly I:C (TLR-3), and measured the levels of TNF-a and IL-
6 in culture supernatants. Results confirmed that CD200/
Bg-PM produced significantly higher levels of TNF-a and IL-6
in response to all three TLR agonists (Figure 5). Since
CD200/ Mf showed a heightened cytokine response to bothptember 16, 2010 ª2010 Elsevier Inc. 239
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Figure 3. CD200–/– Mice Are More Suscep-
tible to Meningococcal Septicemia
Cohorts of WT and CD200/mice were i.p. inoc-
ulated with live NM.
(A) The health of the animals was monitored regu-
larly and scored by a semiquantitative method.
Collated scores for each time point are plotted.
(B) The survival of each group was plotted, and the
statistical comparisonwas performedwith the log-
rank (Mantel Cox) test (p = 0.0031).
(C) Blood was collected by cardiac puncture at
termination, and serial dilutions were plated on
bacterial growth medium. Spleen segments were
also collected, homogenized, and plated. Plates
were incubated at 37C, 5% CO2 overnight, and
bacterial colonies counted. Results were analyzed
with a two-tailed, unpaired t test. No significant
difference in bacterial count was observed
between two mouse strains.
(D) The concentration of IL-6 in plasma from in-
fected animals was measured at termination with
an ELISA. Results were analyzed with a two-tailed,
unpaired t test to determine statistical signifi-
cance. **, p < 0.01.
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CD200 Inhibits TLR and NLR FunctionMyD88-dependent and -independent TLR stimuli, we conclude
that CD200-CD200R interaction negatively regulates both arms
of the TLR signaling response.CD200 Is Induced by NOD2 Ligand and Limits NOD2-
Mediated Inflammation In Vivo and In Vitro
Unlike TLRs, NOD2 is a cytosolic sensor for bacterial cell wall
components such as muramyl dipeptide (MDP), but also acti-
vates NF-kB signaling through the specific adaptor RIP2 (Tattoli
et al., 2007). We showed that NOD2-mediated c-Rel activation
was able to induce CD200. Bg-PM from WT and c-Rel/ mice
were first primed with recombinant IFN-g and then stimulated
with 100 mg/ml muramyl dipeptide (MDP) to activate NOD2.
Induction of CD200 mRNA was detected by quantitative PCR
(qPCR) after different times. MDP stimulation significantly
induced CD200 mRNA in WT Mf but completely failed to induce
CD200 in c-Rel/ Mf (Figure 6A), indicating that NOD2-medi-
ated c-Rel activation can also induce CD200. To investigate
any potential influence of CD200 on a NOD2-mediated inflam-
matory response, we primed Bg-PM from WT and CD200/
mice with IFN-g and then stimulated them with different concen-
trations of MDP. CD200/ Mf produced significantly higher
levels of TNF-a and IL-6 in response to MDP (Figure 6B).
The levels of TNF-a and IL-6 were consistently higher in perito-
neal lavage fluid from CD200/ mice after intraperitoneal MDP
challenge, indicating that the CD200/CD200R axis also nega-
tively regulates NOD2-mediated inflammatory signaling
(Figure 6C). To exclude the possibility that our MDP preparation
was contaminated with TLR agonists, we measured TNF-a and240 Cell Host & Microbe 8, 236–247, September 16, 2010 ª2010 Elsevier Inc.IL-6 secretion in MyD88/ mice after
similar intraperitoneal MDP challenge.
MyD88/ mice produced similar levels
of TNF-a and even higher levels of IL-6
compared to WT mice, indicating that
our MDP preparation was not contami-nated with TLR agonists (Figure 6C). Similar to Fig-4, PBS-in-
jected groups did not induce any cytokine in either mouse strain
(data not shown).
CD200 Is Induced by Agonists of NALP3 Inflammasomes
and Limits Caspase-1 Activation and IL-1b Secretion
NALP3 is another cytosolic pathogen sensor. Unlike TLRs and
NOD2, NALP3 stimulation does not activate NF-kB, but rather
activates caspase-1, which in turn cleaves pro-IL-1b to mature
IL-1b. However, transcriptional induction of pro-IL-1b depends
on TLR stimulation. Therefore, NALP3 contributes to inflamma-
tion by regulating secretion of inflammatorymediators but, unlike
TLRs and NOD2, does not regulate gene expression. Since TLRs
and NOD2 induced CD200, we investigated whether direct acti-
vation of NALP3 itself can activate CD200 expression in the
absence of MyD88 and c-Rel. BMDM from WT, MyD88/,
and c-Rel/ mice were stimulated with LPS for 6 hr and briefly
pulsed with 1 mM adenosine triphosphate (ATP) to activate the
NALP3 inflammasome (LPS and ATP individually do not activate
NALP3 but together are a potent agonist of NALP3). Induction of
CD200 mRNA was analyzed by qPCR after different times
following the ATP pulse. Consistent with results in Figure 2,
LPS treatment alone induced high levels of CD200 in WT cells,
but not inMyD88/ and c-Rel/Mf. Interestingly, a short pulse
of ATP after LPS treatment induced CD200 mRA in MyD88/
Mf but much lower levels in c-Rel/ Mf, suggesting that direct
stimulation by the known NALP3 agonists LPS+ATP may induce
CD200 independent of the MyD88-mediated pathway but still
require c-Rel (Figure 7A). Although c-Rel/Mf show significant
AC
B
Figure 4. CD200–/– Mf Show Increased Cellular and Secretory Inflammatory Responses to Inactivated Neisseria In Vivo and In Vitro
(A) The distribution of leukocyte populations was determined by flow cytometry 2 hr after injection (i.p) of WT and CD200/ mice with 105 cfu of inactivated
Neisseria or equal volumes of control PBS. Resident Mf were identified as F4/80hiCD11bhiGR-1-veCD11c-ve and CD19-ve. Data are shown as mean ± SD,
with 6 mice per group, and are representative of three independent experiments. The two-way ANOVA with Bonferroni multiple comparison test was used to
assess statistical significance. Inset: histograms comparing MHC-II expression on Mf populations between PBS-treated WT (red line) and CD200/
(blue line) mice, as well as NM-treatedWT (green line) and CD200/ (brown line) mice. All comparisons between two genotypes as well as comparisons between
two treatment conditions within the same genotype are statistically significant, as above (not shown).
(B) Enhanced cytokine production in CD200/ mice after injection of inactivated NM compared to PBS control. Secretion of TNF-a (left panel) and IL-6 (middle
panel) wasmeasured 2 hr after injection in peritoneal lavage fluid by ELISA. Two-way ANOVAwith Bonferroni multiple comparison test was used to assess statis-
tical significance. **, p < 0.01.
RdGNX-labeled NM (106 cfu) were injected into the peritoneal cavity of WT and CD200/mice. After 90 min, peritoneal exudate cells were harvested by lavage
and bacterial uptake was analyzed by flow cytometry (right panel). No significant difference in bacterial uptake was observed between the two mouse strains.
Data are shown as mean ± SD.
(C) Enhanced cytokine production in Bg-PM from CD200/mice after NM stimulation. TNF-a (left panel) and IL-6 (middle panel) concentrations were measured
in supernatants after 16 hr stimulation of WT and CD200 Bg-PMwith indicated doses of inactivated NM. Data are presented after normalizing the total number of
cells in each well (mean ± SD). Two-way ANOVA with Bonferroni multiple comparison test was used to assess statistical significance. **, p < 0.01
Bg-PM from WT and CD200/ animals show comparable levels of NM uptake. Bg-PM were incubated with indicated doses of Rd-GNX-labeled fluorescent
Neisseria for 90 min. The mean fluorescent intensity (MFI) of each strain is presented as a bar diagram (right panel). No significant difference in NM uptake
was observed between the two strains. All data shown are representative of at least three independent experiments.
Cell Host & Microbe
CD200 Inhibits TLR and NLR Functionattenuation of CD200 induction after stimulation, a low-level
induction of CD200 mRNA was observed at a later time point.
Therefore, c-Rel/ Mf show strikingly slower kinetics of
CD200 induction rather than complete inhibition.
To investigate whether CD200 alsomodulates IL-1b secretion,
we stimulated WT and CD200/ Mf with LPS for 6 hr to induceCell Host &pro-IL-b, followed by a short pulse of ATP or monosodium urate
crystal (MSU, another activator of NALP3 mediated pro-IL-1b
secretion), and after further 6 hr of incubation, we harvested
supernatants and measured secretion of IL-1b by ELISA. The
CD200/ Mf produced higher levels of IL-1b compared to WT
Mf, indicating that CD200 also negatively regulated IL-1bMicrobe 8, 236–247, September 16, 2010 ª2010 Elsevier Inc. 241
Figure 5. CD200–/– Mf Produce Enhanced
Levels of TNF-a and IL-6 In Vitro, in
Response to MyD88-Dependent and -Inde-
pendent TLR Agonists
WT and CD200/ Bg-PM were cultured on
96-well bacteriologic plastic dishes in serum-free
conditions. Quadruplicate wells were stimulated
with increasing concentrations of purified TLR-4
(LPS), TLR-2/6 (PGN), and TLR-3 (poly I:C)
agonists. After 16 hr incubation, supernatants
were harvested and TNF-a and IL-6 concentra-
tions were measured by ELISA. Data (mean ± SD,
with at least 3 mice per group) are presented after
normalizing for cell numbers in each condition and
are representative of at least three independent
experiments. Two-way ANOVA with Bonferroni
multiple comparison test was used to assess
statistical significance. ***, p < 0.001.
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CD200 Inhibits TLR and NLR Functionsecretion (Figure 7B). In the above assay, once the LPS priming
step was replaced by NM stimulation, CD200/ Mf still
produced significantly higher levels of IL-1b (data not shown).
We further validated the role of CD200 inmodulating IL-1b secre-
tion in vivo. CD200/ mice produced significantly higher levels
of IL-1b, confirming that CD200 also negatively regulates IL-1b
release in vivo (Figure 7C). As expected, vehicle-injected groups
did not induce any detectable cytokine in either mouse strain
(data not shown).
We investigated whether CD200 limits IL-1b secretion just by
limiting its TLR-mediated transcriptional induction or whether
CD200 can also regulate caspase-1 activation, thereby limiting
conversion of pro-IL-1b to active IL-1b. LPS-primed WT and
CD200/ Mf were stimulated with 5 mM ATP to activate
NALP3 inflammasome. Caspase-1 activation was measured by
a quantitative flow-cytometry-based method after staining the
cells with a cell permeable fluorescent probe (FLICA) that specif-
ically recognizes active caspase-1. Results show that after LPS
+ATP stimulation, CD200/ Mf expressed markedly enhanced
active caspase-1 compared to WT cells (Figure 7D). LPS stimu-
lation alone did not show any caspase-1 activation, but ATP
alone induced low-level activation in both strains. These data
indicate that CD200 can inhibit inflammasome activation and242 Cell Host & Microbe 8, 236–247, September 16, 2010 ª2010 Elsevier Inc.may regulate IL-1b secretion not just by
modulating TLR pathways, but also by
limiting caspase-1 activation.
DISCUSSION
We show that CD200 and CD200R are
differentially regulated on innately acti-
vated Mf after stimulation with agonists
of TLRs, NOD2 and NALP3 inflamma-
some, but not by the ligation of the
phagocytic pattern recognition receptor
SR-A. Induction of CD200 depended on
the transcription factor c-Rel and nega-
tively regulated TLR and NOD2 and in-
flammasome-mediated responses. Lackof CD200 also increased the accumulation of different inflam-
matory leukocyte populations at the site of induced inflamma-
tion. Therefore, TLR and NLR activation induces CD200 and
initiates a negative regulatory loop, which in turn regulates
TLR- and NLR-mediated cellular and secretory inflammatory
responses. The importance of such negative regulation in host
defense was evident from the finding that CD200/ mice suc-
cumbed more readily to meningococcal septicemia, showing
clear signs of exacerbated systemic inflammation.
TLR- and NOD2-mediated induction of CD200 was transcrip-
tionally regulated by the NF-kB family member c-Rel. Induction
of CD200 by combined LPS and ATP stimulation in the absence
of MyD88 is highly suggestive of involvement of NALP3 and cas-
pase-1 in the regulation of CD200 transcription. One unexpected
finding was that such MyD88-independent CD200 induction still
required c-Rel, indicating a possible transcriptional regulatory
loop between caspase-1 and c-Rel. It is interesting to note that
caspase-1/ Mf show reduced NF-kB activation (Sarkar et al.,
2006). Similarly, caspase-8/ cells displayed diminished c-Rel
activation and nuclear translocation (Falk et al., 2004). Pharmaco-
logical inhibition of caspases by the pan-caspase inhibitor ZVAD-
FMK has been shown to inhibit CD200 induction (Rosenblum
et al., 2004). Our finding that downregulation of CD200R is not
AB
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Figure 6. CD200 Is Induced by NOD2 Stimulation
and Negatively Regulates Its Function
(A) CD200 mRNA was induced in Bg-PM from WT but not
c-Rel/ mice that had been primed overnight with 20 ng/ml
of recombinant IFN-g and then stimulated with 100 mg/mlMDP
for indicated times. CD200 mRNA was determined by real-
time PCR, and fold induction is presented as a bar diagram.
Data are shown as mean ± SD, with 3 mice per group.
(B) Increased levels of TNF-a and IL-6 were produced in
CD200/ Mf primed overnight with IFN-g and then chal-
lenged with indicated concentrations of MDP for 16 hr. Levels
of TNF-a and IL-6 were measured by ELISA. Data are shown
as mean ± SD, with at least 3 mice per group. Two-way
ANOVA with Bonferroni multiple comparison test was used
to assess statistical significance. ***, p < 0.001.
(C) Increased levels of TNF-a and IL-6 were produced in the
peritoneal cavity of CD200/ injected (i.p.) with 100 mg MDP
or an equal volume of PBS. After 2 hr, animals were killed
and peritoneal lavage was performed with 1 ml PBS. Levels
of TNF-a and IL-6 were measured by ELISA. Two-tailed
t test was performed to determine statistical significance. *,
p < 0.01; **, indicates p < 0.001.
Each condition was analyzed in triplicate and representative
data from at least three independent experiments are shown.
Cell Host & Microbe
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late expression of CD200 and CD200R by distinct mechanisms.
The inhibitory role of CD200-CD200R engagement is well
characterized during chronic autoimmune inflammatory models,
where adaptive immunity plays an important role in disease
pathogenesis. Their role in regulating innate responses to bacte-
rial challenge was investigated in an established experimental
model of acute meningococcal septicemia. Live organisms
confirmed that the enhanced susceptibility of CD200/ mice
to meningococcal challenge was associated with accumulation
of activated leukocytes and increased secretion of inflammatory
mediators, rather than bacterial overgrowth. Additional chal-
lenge with inactivated bacteria and selective agonists not only
defined the specificity of each PRR system but also ruled out
potential immune modulation by live organisms and the exoge-
nous ironsupplement, required formeningococcalgrowth inmice.
A range of negative regulators control excessive activation of
various adaptive and innate immune pathways, including TLR
and NLR pathways (Liew et al., 2005). Compared to other inhib-
itory molecules, the CD200-CD200R pathway stands out for its
several distinct features.
Unlike most inhibitory receptors that signal through immunor-
eceptor tyrosine-based inhibitory motifs (ITIMs) and phospha-
tase recruitment, CD200R recruits the adaptor protein down-Cell Host & Microbe 8, 23stream of tyrosine kinase 2 (Dok2), which in turn
recruits its target RAS p21protein activator 1 (Ras-
GAP), leading to inhibition of ERK, JNK, and p38
MAPK activation (Mihrshahi et al., 2009; Zhang
et al., 2004). These interactions may regulate
TLR and NLR function by limiting nuclear translo-
cation of NF-kB (Cui et al., 2007). Indeed, Dok2
has been shown to be a potent regulator of
TLRs. (Shinohara et al., 2005).
CD200 is the only regulatory pathway to our
knowledge that has been shown to limit functionsof all three innate pathogen sensors—namely, TLR, NOD2
response, and inflammasome-mediated caspase-1 activation
as well as IL-1b secretion. We show that CD200-CD200R inter-
action limits IL-1b secretion not just by inhibiting TLR-mediated
pro-IL-b induction but also by limiting inflammasome-mediated
caspase-1 activation. Since CD200-CD200R axis limits overall
secretion of bioactivemature IL-1b, our data further demonstrate
the central importance of this inhibitory pathway in controlling
inflammation. However, CD200 is not an indiscriminate immuno-
suppressant, since it did not block phagocytic uptake or bacte-
rial killing. Furthermore, CD200-CD200R interaction enhances
IFN-a/b production by plasmacytoid dendritic cells after viral
stimulation (Fallarino et al., 2004). However, CD200 clearly plays
an important role in limiting bacterial sepsis as shown here, as
well as excessive inflammation induced by viruses (Snelgrove
et al., 2008) and autoimmune pathologies (Copland et al.,
2007; Hoek et al., 2000).
Many negative regulators of TLRs function through cis-cellular
mechanisms acting on the same cells, but CD200 induces its
inhibitory effects through a trans-cellular mechanism by cell-cell
contact (Hatherley and Barclay, 2004). There are not many
examples showing the importance of cell-cell regulatory path-
ways in infection; our data clearly showed the distinct kinetics
of the early inflammatory response allowing pathogen killing,6–247, September 16, 2010 ª2010 Elsevier Inc. 243
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Figure 7. CD200 Is Induced by NALP3 Activation and Limits IL-1b Secretion
(A) WT,MyD88/, and c-Rel/Mfwere stimulated with 100 ng/ml of LPS for 6 hr and pulsed for 5minwith 5mMATP. RNAwas collected for the indicated times
after the pulse and induction of CD200 mRNA was determined by real-time PCR. Fold induction is presented as a bar diagram. Data are shown as mean ± SD,
with 3 mice per group.
(B)WT andCD200/Mfwere stimulated for 6 hr with indicated concentrations of LPS and either pulsed for 5min with 5mMATP or stimulated with 5 mg/mlMSU.
After 6 hr, supernatants were harvested and the levels of IL-1bwere measured by ELISA. Data are shown as mean ± SD, with at least 3 mice per group. Two-way
ANOVA with Bonferroni multiple comparison test was used to assess statistical significance. ***, p < 0.001.
(C) CD200/mice produce more IL-1b in peritoneal lavage fluid after i.p. injection with inactivated NM followed by ATP. After 2 hr, mice were killed and levels of
IL-1b in peritoneal lavage fluid were measured by ELISA. Two-tailed t test was performed to determine statistical significance. ***, p < 0.001.
Each condition was analyzed in triplicate, and representative data from at least three independent experiments are shown.
(D) WT and CD200/ Mf were stimulated with LPS (100 ng/ml), ATP (5 mM) and LPS+ATP. Induction of active caspase-1in the two strains was compared by
staining with a specific fluorescent probe. Each condition was analyzed at least in duplicate and representative data from three independent experiments are
shown.
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response. It is worth noting that CD200/ mice showed
enhanced disease severity only after a lag of 30–40 hr after infec-
tion. Thus direct induction of CD200 by microbial stimuli not only
distinguishes cytokine versus innate activation of Mf but also
functionally defines the latter population. Taken together,
we conclude that CD200 is selectively induced by TLR- and
NLR-mediated inflammatory pathways and, interacting through
CD200R, limits excessive inflammation without compromising
pathogen killing, therefore providing an attractive therapeutic
target.
Most negative regulators are part of negative feedback loops
induced by TLR signaling itself and then inhibiting TLR function.
Induction of CD200 by innate stimuli is in agreement with such
a paradigm, but simultaneous reduction in signal-competent
CD200R may seem counterintuitive. However, similar examples
are not uncommon among paired receptors. A close relative of
CD200-CD200R is the paired inhibitory receptor signal regula-
tory protein alpha (SIRPa) and its ligand CD47. A recent report
showed that SIRPa also protects the host from LPS-induced
septic shock and, similar to CD200R, itself is downregulated
on Mf after LPS stimulation (Kong et al., 2007). Downregulation
of inhibitory receptors such as SIRPa and CD200R are possibly
required to allow host protective physiological inflammation, but
may prolong pathological inflammation. Induction of ligands
such as CD200 possibly balances this risk by maximizing the
chance of engagement of available receptors. We propose that
distinct regulation patterns of CD200 and CD200R by inflamma-
tory stimuli is an integral part of their inhibitory function, which
allows efficient host protection but limits inflammatory patholo-
gies. Our findings may provide a common paradigm for how
these paired receptors regulate excessive inflammation.
EXPERIMENTAL PROCEDURES
Chemicals and Reagents
Unless stated otherwise, all chemicals were from Sigma (Poole, United
Kingdom). Rhodamine green X (RdGnX) was obtained from Molecular Probes
(Eugene, OR, USA). The TMB substrate reagent set was purchased from BD
PharMingen (San Diego, CA). All cell-culture media were from GIBCO (Paisley,
United Kingdom). All TLR and NLR agonists were obtained from Invivogen
(Wiltshire, UK). The rat monoclonal antibodies against F4/80 (Austyn and
Gordon, 1981) and CD11b (5C6) (Rosen and Gordon, 1987) were generated
in the Gordon laboratory. The rat monoclonal antibodies against murine
CD200 (OX-90) and CD200R (OX-110) were generated in the Barclay labora-
tory. M5114, the rat monoclonal antibody recognizing murine MHC-II, was
obtained from R&D Systems (Abingdon, UK).
Bacterial Culture and Fluorescent Labeling
The encapsulated serogroup B strains of pathogenic Neisseria meningitidis
MC58, H44/76, and its isogenic lipid A mutant strain H44/76lpxA (van der
Ley et al., 1996) were cultured in an atmosphere of 5% CO2 overnight at
37C on brain-heart infusion (BHI) medium (Oxoid, Basingstoke, UK),
supplemented with Levinthal’s reagent (10% vol/vol) and solidified with agar
(1% wt/vol). For fluorescent labeling, NM were harvested and resuspended
in 70% ethanol overnight at 4C and labeled with RdGnX (RdGnX-NM) (Peiser
et al., 2006).
Mouse Strains
SR-A/ (Suzuki et al., 1997), MyD88/ (Adachi et al., 1998), CD200/ (Hoek
et al., 2000), and c-Rel/mouse strains were on a C57BL/6J background and
kindly provided by original investigators. Balb/c, C57BL/6J, a mutant for
TLR-4, and C3H/HeJ and its corresponding WT control, C3H/HeN, wereCell Host &from Harlan, UK. All animals were housed in specific pathogen-free conditions
and procedures were conducted according to the requirements of the United
Kingdom Home Office Animals Scientific Procedures Act, 1986.
Isolation and Culture of Primary Mf
Bg-PM and TPM were prepared by intraperitoneal (i.p.) injection of 1 ml poly-
acrylamide gel P-100 (Bio-Rad) beads (2% w/v suspension in endotoxin-free
PBS) and thioglycollate broth (2% solution), respectively . Four days after
injection, cells were harvested by peritoneal lavage with ice-cold PBS. Simi-
larly, resident peritoneal Mf (RPM) were isolated from uninjected animals by
lavage with PBS. Bg-PM, TPM, and RPM were plated on bacteriological
plastic dishes in a defined serum-free medium, OPTIMEM-1, supplemented
with 500 IU/ml penicillin-streptomycin and 2 mM-glutamine. After 3–4 hr,
plates were washed three times to remove nonadherent cells and bio-gel
beads. After washing, purity of Mf in the adherent monolayer was > 98%.
Bone marrow was isolated aseptically from femur and tibia and differentiated
into mature bone marrow-derived Mf by culturing in RPMI supplemented with
100 IU/ml penicillin-streptomycin, 2 mM-glutamine, 10% fetal calf serum
(FCS), and 10% L cell-conditioned medium (LCM).
In Vitro Stimulation of Mf to Activate TLR and NLR Pathways
For activation of TLR pathways, Mf were stimulated with either indicated
concentrations of inactivated NM or isolated TLR agonists. For activation of
NOD2, cells were first primed with 20 ng/ml recombinant murine IFN-g and
then stimulated with muramyl dipeptide (MDP). NALP3 inflammasomes were
activated by stimulating Mf with LPS or inactivated NM, followed by a short
pulse of ATP or MSU crystals. We assessed cell viability by trypan blue exclu-
sion method in both genotypes before and after stimulation and observed no
significant cell death in any condition. After Mf stimulation, cytokine secretion
and surface-molecule expression were analyzed.
Caspase-1 Activation Assay
WT and CD200/Mfwere primed with 100 ng/ml LPS for 5 hr and stimulated
with 5 mM ATP for 30 min. ATP-containing media were replaced with fresh
media and incubated for another 30 min to allow active caspase-1 accumula-
tion. Cells were washed and stained with an active caspase-1-specific fluores-
cent probe (FLICA kit, Immunochemistry Technologies, MN, USA) according
to the manufacturer’s instructions and analyzed by flow cytometry.
Mouse Infection Studies
This method is adapted from Gorringe et al. (2001) and Plu¨ddemann et al.
(2009). In brief, groups of 6- to 8-week-old CD200/mice and corresponding
age- and sex-matched C57BL/6J were injected i.p. with 1 3 105 CFU of se-
rogroup B Neisseria strain MC58 together with human holo-transferrin
(10 mg) in a total volume of 500 ml. At 18 hr after initial injection, mice were in-
jected i.p. with a second dose of human holo-transferrin (10 mg). The health of
the animals was monitored and scored at various time points according to the
symptoms presented as follows: healthy = 5, ruffled fur = 4, sticky eyes = 3,
ruffled fur and sticky eyes = 2, immobile = 1. As soon as immobile mice
were detected, they were killed humanely. Scores were collated and averaged
for each group at the various time points. Five microliter blood samples were
taken at 20 hr and 24 hr after infection, and serial dilutions were plated to deter-
mine bacteremia. At termination, blood was collected by cardiac puncture and
spleens recovered. Tissue was homogenized, and serial dilutions of spleen
and blood were plated to determine bacteremia. The remaining blood was
centrifuged and the plasma collected and frozen at 80C for later use.
Sterile Peritonitis Model
For the induction of sterile peritonitis, mice were injected i.p. with 23 106 cfu of
ethanol-inactivatedNMor 100 mg purifiedMDP suspended in 200 ml PBS.Mice
in the control group were injected with the same volume of PBS. Two hours
after injection, mice were killed and inflammatory cells were collected by peri-
toneal lavage with 1 ml ice-cold PBS, to avoid dilution of cytokines. Care was
taken to avoid erythrocyte contamination. Cells were separated by centrifuga-
tion, and leukocyte populations were analyzed bymulticolor flow cytometry by
staining with well-characterized cell-type-specific markers. Cytokine levels in
lavage fluid weremeasured by ELISA. For the assessment of NALP3-mediated
IL-1b secretion, 200 ml of ATP (1 mM, pH 7.4) were injected 2 hr after the firstMicrobe 8, 236–247, September 16, 2010 ª2010 Elsevier Inc. 245
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from Griffiths et al. (1995).
Real-Time PCR
Mf were stimulated with 100 ng/ml LPS, 100 nM CpG, 2 mg/ml peptidogly-
cans, 1.8 mg/ml poly I:C, 25–100 mg/ml MDP, and/or 20 ng/ml recombinant
mouse IFN-g (BD Bioscience, San Diego). RNA was extracted with TRI-
reagent, treated with Rnase-free Dnase I, and purified with an Rneasy kit
(QIAGEN, USA). Two micrograms of RNA were reverse transcribed with the
Omniscript RT kit (QIAGEN, USA) with random hexamer primer. Resulting
cDNA was analyzed by real-time PCR. Each reaction was prepared with
0.253 SYBR Green I nucleic acid stain (Invitrogen), 10 nM FITC (Bio-Rad,
USA), 50 mM KCl, 20 mM Tris-HCl (pH 8.3), 25 mM MgCl2, 100 mg/ml BSA,
and 4 mM dNTPs (Denville) with 1.25 U ‘‘Choice’’ Taq (Denville, USA). Real-
time PCR amplification conditions were 95C (3 min) and 45 cycles of 95C
(15 s), 60C (30 s), and 72C (30 s). The following primers were used: Cd200,
50-ATCCTGAGCACGCTGATTTT-30 and 50-GCCAGGGAAATGTCCTCATA-30;
GAPDH, 50-TGGTGAAGGTCGGTGTGAAC-30 and 50-CCATGTAGTTGAGGT
CAATGAAGG-30.
Cytokine Analysis
Interleukin-6 and tumor necrosis factor-a (TNF-a) concentration was deter-
mined with OptEIA Mouse IL-6 and TNF-a ELISA set (BD Biosciences, San
Diego), and IL-1b concentration was determined with an ELISA kit from eBio-
science, UK. All analyses were performed according to the manufacturer’s
instructions.
Flow Cytometry to Assay Surface Antigen Expression
and Association of Bacteria
Single or multicolor flow cytometry was performed on isolated primary Mf or
amixed population of peritoneal exudate cells to analyze expression of various
surface antigens. Antibody staining was performed according to conventional
protocols at 4C in the presence of 2mMNaN3. Cells were blocked for 2 hr with
5% heat-inactivated rabbit serum, 0.5% BSA, 5 mM EDTA, and 10 mg/ml
2.4G2 (anti-FcgRII and III) prior to addition of primary antibodies. Directly
conjugated primary antibodies were added at concentrations recommended
by the supplier and incubated for another 2 hr. Biotinylated antibodies were
detected with streptavidin-phycoerythrin (BD PharMingen). Cells were fixed
with 1% formaldehyde in PBS for 2 hr on ice; between steps, cells were
washed thoroughly with FACS wash buffer. Fixed cells were analyzed on
a BD FACScalibur, with either Cell Quest or Flo-Jo software. Association of
fluorescently labeled NM to various Mf populations was determined by flow
cytometry, as reported previously (Peiser et al., 2006).
Statistical Analysis
Data were analyzed with commercial software (GraphPad Software). One-way
ANOVA with Bonferroni posttests was used when multiple groups were
analyzed and the two-tailed Student’s t test was used for analysis of two
groups. Survival data were analyzed with the log-rank test. Results were
considered statistically significant with p values of less than 0.05. Unless
stated otherwise, all experiments were repeated at least three times and repre-
sentative data are presented.
SUPPLEMENTAL INFORMATION
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